Cronbach's a is the most widely used index of the reliability of a scale. However, its use and interpretation can be subject to a number of errors. This article discusses the historical development of a from other indexes of internal consistency (split-half reliability and Kuder-Richardson 20) and discusses four myths associated with a: (a) that it is a fixed property of the scale, (b) that it measures only the internal consistency of the scale, (c) that higher values are always preferred over lower ones, and (d) that it is restricted to the range of 0 to 1. It provides some recommendations for acceptable values of a in different situations.
One of the central tenets of classical test theory is that scales should have a high degree of internal consistency, as evidenced by Cronbach's a, the mean interitem correlation, and a strong first component. However, there are many instances in which this rule does not apply. Following Bollen and Lennox (1991), I differentiate between questionnaires such as anxiety or depression inventories, which are composed of items that are manifestations of an underlying hypothetical construct (i.e., where the items are called effect indicators) and those such as Scale 6 of the Minnesota Multiphasic Personality Inventory (Hathaway & McKinley, 1943) and ones used to tap quality of life or activities of daily living in which the items or subscales themselves define the construct (these items are called causal indicators). Questionnaires of the first sort, which are referred to as scales in this article, meet the criteria of classical test theory, whereas the second type, which are called indexes here, do not. I discuss the implications of this difference for how items are selected, the relationship among the items, and the statistics that should and should not be used in establishing the reliability of the scale or index.
IntroductionHousing First is a complex housing and support intervention for homeless individuals with mental health problems. It has a sufficient knowledge base and interest to warrant a test of wide-scale implementation in various settings. This protocol describes the quantitative design of a Canadian five city, $110 million demonstration project and provides the rationale for key scientific decisions.MethodsA pragmatic, mixed methods, multi-site field trial of the effectiveness of Housing First in Vancouver, Winnipeg, Toronto, Montreal and Moncton, is randomising approximately 2500 participants, stratified by high and moderate need levels, into intervention and treatment as usual groups. Quantitative outcome measures are being collected over a 2-year period and a qualitative process evaluation is being completed. Primary outcomes are housing stability, social functioning and, for the economic analyses, quality of life. Hierarchical linear modelling is the primary data analytic strategy.Ethics and disseminationResearch ethics board approval has been obtained from 11 institutions and a safety and adverse events committee is in place. The results of the multi-site analyses of outcomes at 12 months and 2 years will be reported in a series of core scientific journal papers. Extensive knowledge exchange activities with non-academic audiences will occur throughout the duration of the project.Trial registration numberThis study has been registered with the International Standard Randomised Control Trial Number Register and assigned ISRCTN42520374.
These results suggest that individuals with borderline personality disorder benefited equally from dialectical behavior therapy and a well-specified treatment delivered by psychiatrists with expertise in the treatment of borderline personality disorder.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.